MAPK3 and neoplasm: Substantial evidence exists that the phosphorylation of ERK1/2 could increase cell proliferation and cause an anti-apoptotic effect, thereby promoting the progression of tumor invasion and metastasis (Lebedev et al., 2022; Wang et al., 2022).